150 related articles for article (PubMed ID: 12975469)
1. JunD protects against chronic kidney disease by regulating paracrine mitogens.
Pillebout E; Weitzman JB; Burtin M; Martino C; Federici P; Yaniv M; Friedlander G; Terzi F
J Clin Invest; 2003 Sep; 112(6):843-52. PubMed ID: 12975469
[TBL] [Abstract][Full Text] [Related]
2. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
3. Jun and JunD-dependent functions in cell proliferation and stress response.
Meixner A; Karreth F; Kenner L; Penninger JM; Wagner EF
Cell Death Differ; 2010 Sep; 17(9):1409-19. PubMed ID: 20300111
[TBL] [Abstract][Full Text] [Related]
4. Functional cooperation between JunD and NF-kappaB in rat hepatocytes.
Rahmani M; Péron P; Weitzman J; Bakiri L; Lardeux B; Bernuau D
Oncogene; 2001 Aug; 20(37):5132-42. PubMed ID: 11526502
[TBL] [Abstract][Full Text] [Related]
5. JunD phosphorylation, and expression of AP-1 DNA binding activity modulated by serum growth factors in quiescent murine 3T3T cells.
Wang H; Xie Z; Scott RE
Oncogene; 1996 Dec; 13(12):2639-47. PubMed ID: 9000138
[TBL] [Abstract][Full Text] [Related]
6. [Cellular proliferation and apoptosis in the development and progression of renal diseases:pharmacological interventions in genetically modified animals].
Terzi F; Burtin M; Friedlander G
Ann Pathol; 2000; 20 Suppl():S3-5. PubMed ID: 11261294
[No Abstract] [Full Text] [Related]
7. Molecular mechanisms of TGF-(beta) antagonism by interferon (gamma) and cyclosporine A in lung fibroblasts.
Eickelberg O; Pansky A; Koehler E; Bihl M; Tamm M; Hildebrand P; Perruchoud AP; Kashgarian M; Roth M
FASEB J; 2001 Mar; 15(3):797-806. PubMed ID: 11259398
[TBL] [Abstract][Full Text] [Related]
8. Presence of distinct AP-1 dimers in normal and transformed rat hepatocytes under basal conditions and after epidermal growth factor stimulation.
Nadori F; Lardeux B; Rahmani M; Bringuier A; Durand-Schneider AM; Bernuau D
Hepatology; 1997 Dec; 26(6):1477-83. PubMed ID: 9397987
[TBL] [Abstract][Full Text] [Related]
9. Jun signalling in the epidermis: From developmental defects to psoriasis and skin tumors.
Zenz R; Wagner EF
Int J Biochem Cell Biol; 2006; 38(7):1043-9. PubMed ID: 16423552
[TBL] [Abstract][Full Text] [Related]
10. TGF-β1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner.
Wygrecka M; Zakrzewicz D; Taborski B; Didiasova M; Kwapiszewska G; Preissner KT; Markart P
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):614-27. PubMed ID: 22771387
[TBL] [Abstract][Full Text] [Related]
11. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.
Soto U; Das BC; Lengert M; Finzer P; zur Hausen H; Rösl F
Oncogene; 1999 May; 18(21):3187-98. PubMed ID: 10359524
[TBL] [Abstract][Full Text] [Related]
12. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
[TBL] [Abstract][Full Text] [Related]
13. Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart.
Hilfiker-Kleiner D; Hilfiker A; Kaminski K; Schaefer A; Park JK; Michel K; Quint A; Yaniv M; Weitzman JB; Drexler H
Circulation; 2005 Sep; 112(10):1470-7. PubMed ID: 16129800
[TBL] [Abstract][Full Text] [Related]
14. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability.
Dosch J; Kaina B
Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539
[TBL] [Abstract][Full Text] [Related]
15. p202 levels are negatively regulated by serum growth factors.
Geng Y; D'Souza S; Xin H; Walter S; Choubey D
Cell Growth Differ; 2000 Sep; 11(9):475-83. PubMed ID: 11007452
[TBL] [Abstract][Full Text] [Related]
16. Expression and distribution of AP-1 transcription factors in the porcine ovary.
Rusovici R; LaVoie HA
Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371
[TBL] [Abstract][Full Text] [Related]
17. Successive occupancy by immediate early transcriptional factors of the tyrosine hydroxylase gene TRE and CRE sites in PACAP-stimulated PC12 pheochromocytoma cells.
Yukimasa N; Isobe K; Nagai H; Takuwa Y; Nakai T
Neuropeptides; 1999 Dec; 33(6):475-82. PubMed ID: 10657527
[TBL] [Abstract][Full Text] [Related]
18. AP-1 mediated retinal photoreceptor apoptosis is independent of N-terminal phosphorylation of c-Jun.
Grimm C; Wenzel A; Behrens A; Hafezi F; Wagner EF; Remé CE
Cell Death Differ; 2001 Aug; 8(8):859-67. PubMed ID: 11526439
[TBL] [Abstract][Full Text] [Related]
19. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.
Reddy CC; Wells A; Lauffenburger DA
J Cell Physiol; 1996 Mar; 166(3):512-22. PubMed ID: 8600155
[TBL] [Abstract][Full Text] [Related]
20. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
